EMEIS SA (ORP.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ORP - FR001400NLM4 - Common Stock
12.465 EUR
+0.15 (+1.24%)
Taking everything into account, ORP scores 4 out of 10 in our fundamental rating. ORP was compared to 27 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ORP while its profitability can be described as average. ORP is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year ORP was profitable.
ORP had a positive operating cash flow in the past year.
Of the past 5 years ORP 4 years were profitable.
Each year in the past 5 years ORP had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 9.74%, ORP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 71.82%, ORP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.74% | ||
| ROE | 71.82% | ||
| ROIC | N/A |
ROA(3y)-5.89%
ROA(5y)-3.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 26.07%, ORP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ORP's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for ORP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 26.07% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y32.24%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ORP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ORP has been reduced compared to 1 year ago.
Compared to 5 years ago, ORP has less shares outstanding
ORP has a better debt/assets ratio than last year.
2.2 Solvency
ORP has an Altman-Z score of 0.39. This is a bad value and indicates that ORP is not financially healthy and even has some risk of bankruptcy.
ORP has a worse Altman-Z score (0.39) than 85.71% of its industry peers.
A Debt/Equity ratio of 4.30 is on the high side and indicates that ORP has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.30, ORP is doing worse than 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.3 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.39 |
ROIC/WACCN/A
WACC5.23%
2.3 Liquidity
A Current Ratio of 0.60 indicates that ORP may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.60, ORP is doing worse than 85.71% of the companies in the same industry.
ORP has a Quick Ratio of 0.60. This is a bad value and indicates that ORP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.60, ORP is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 360.39% over the past year.
The Earnings Per Share has been growing by 116.08% on average over the past years. This is a very strong growth
The Revenue has grown by 11.04% in the past year. This is quite good.
ORP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.73% yearly.
EPS 1Y (TTM)360.39%
EPS 3Y301.6%
EPS 5Y116.08%
EPS Q2Q%278.1%
Revenue 1Y (TTM)11.04%
Revenue growth 3Y9.84%
Revenue growth 5Y8.73%
Sales Q2Q%11.4%
3.2 Future
ORP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.14% yearly.
ORP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.11% yearly.
EPS Next Y99.7%
EPS Next 2Y41.51%
EPS Next 3Y26.14%
EPS Next 5YN/A
Revenue Next Year6.41%
Revenue Next 2Y9.12%
Revenue Next 3Y8.11%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 1.20, which indicates a rather cheap valuation of ORP.
100.00% of the companies in the same industry are more expensive than ORP, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ORP to the average of the S&P500 Index (26.46), we can say ORP is valued rather cheaply.
ORP is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.2 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ORP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ORP's earnings are expected to grow with 26.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)0.01
EPS Next 2Y41.51%
EPS Next 3Y26.14%
5. Dividend
5.1 Amount
No dividends for ORP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.98B
Revenue(TTM)5.20B
Net Income(TTM)1.35B
Analysts48.89
Price Target170.74 (1269.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-24.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)98.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.2 | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | N/A | ||
| P/OCF | 5.42 | ||
| P/B | 1.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)10.36
EY83.11%
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)2.3
OCFY18.45%
SpS32.65
BVpS11.85
TBVpS-6.36
PEG (NY)0.01
PEG (5Y)0.01
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.74% | ||
| ROE | 71.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 26.07% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-5.89%
ROA(5y)-3.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y32.24%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.3 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.39 |
F-Score6
WACC5.23%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.91%
Cap/Sales(5y)16.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)360.39%
EPS 3Y301.6%
EPS 5Y116.08%
EPS Q2Q%278.1%
EPS Next Y99.7%
EPS Next 2Y41.51%
EPS Next 3Y26.14%
EPS Next 5YN/A
Revenue 1Y (TTM)11.04%
Revenue growth 3Y9.84%
Revenue growth 5Y8.73%
Sales Q2Q%11.4%
Revenue Next Year6.41%
Revenue Next 2Y9.12%
Revenue Next 3Y8.11%
Revenue Next 5YN/A
EBIT growth 1Y81.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.08%
EBIT Next 3Y32.13%
EBIT Next 5YN/A
FCF growth 1Y-135.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.64%
OCF growth 3Y-22.21%
OCF growth 5Y-2.48%
EMEIS SA / ORP.PA FAQ
Can you provide the ChartMill fundamental rating for EMEIS SA?
ChartMill assigns a fundamental rating of 4 / 10 to ORP.PA.
Can you provide the valuation status for EMEIS SA?
ChartMill assigns a valuation rating of 4 / 10 to EMEIS SA (ORP.PA). This can be considered as Fairly Valued.
How profitable is EMEIS SA (ORP.PA) stock?
EMEIS SA (ORP.PA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of EMEIS SA (ORP.PA) stock?
The Price/Earnings (PE) ratio for EMEIS SA (ORP.PA) is 1.2 and the Price/Book (PB) ratio is 1.05.
Is the dividend of EMEIS SA sustainable?
The dividend rating of EMEIS SA (ORP.PA) is 0 / 10 and the dividend payout ratio is 0%.